Patents/Assignees

Chongqing Genrix Biopharmaceutical Co., Ltd.

5 patents in portfolio

US12559556utility2026
BCMA × CD3 T Bispecific Cell Engager
0 cites
US12509520utility2025
Anti-cd3 and Anti-cd123 Bispecific Antibody and Use Thereof
0 cites
US12497455utility2025
Anti-cd3e/bcma Bispecific Antibody and Use Thereof
0 cites
US11897960utility2024
Anti-il-4r Antibody and Use Thereof
0 cites
US11773155utility2023
Bispecific Antibody Against Rabies Virus, and Application Thereof
0 cites